Directorate of Laboratory Medicine

1
Directorate of Laboratory Medicine
Dr Keith Hyde Clinical Director Pat
Zukowskyj Directorate Manager
Corporate Brief
2
Agenda
CSB 3 Planning

CEO Review
Strategic Issues
Autolab
Agenda For Change - Vacancies
Human Resources
Finance
Finance
Trust Developments
Fire Lecture
3
Clinical Director
Dr. Keith Hyde
4
CSB III Planning

• 4 floors laboratory rectangle, core areas
  trapezium many workshops!
• Last Board meeting rectangles presented
• This Board meeting core areas of 1st and 3rd
  floors presented
• Next Board meeting core areas of ground and
  2nd floors hopefully presented!

5
(No Transcript)
6
(No Transcript)
7
CEO Review

• Financial Problems
• Savings Targets
• DLM Pressures e.g. Histopathology
• Triple Whammy
• - CRES/Vacancies
• - ? Activity ()
• - Procurement Savings
• National Targets
• - NSFs, Cancer, Heart
• - Diagnosis to Treatment

8
Strategic Issues

• City-Wide Immunology
• HMDS (1.0m)
• Infection Control
• Mortuary External Review

9
Auto lab Review

• Key Messages
• Accommodation
• Productivity/Efficiency
• Service Delivery
• Resilience
• Introduction IVF/ITU Service
• ?Turn-around Times
• ?Capacity

10
Directorate Manager
Pat Zukowskyj
11
Agenda for Change
100 Submitted! KSFs next
12
SICKNESS
Sickness/absence for DLM (in the 12 months
ending April 2005)
13
Vacancy Update
Summary of vacancies in the Directorate of
Laboratory Medicine 2005/2006 (As at
03.06.2005)Total 4
14
Vacancy Update
Department Number Submitted Number Approved Number Outstanding
Biochemistry 12 9 3
Haematology 13 13 0
Histology 6 6 0
Cytology 9 9 0
Immunology 6 6 0
Microbiology 4 4 0
Virology 4 4 0
DHQ 2 2 0
Operations 7 6 1
TOTAL 63 59 4
15
Finance

• Trust position Annual Deficit 17m. To be
  addressed in 2 ways
• Try to get more from Commissioners (5m)
• 9.0m recurrent and 3m non-recurrent CRES
• Directorate share of this is
• 216,905 recurrent, and 132,600 non-recurrent

16
News
Trust developments which impact on DLM

• There have been recent developments for which
  there are financial implications for the DLM
• These are being pursued

17
Appointment of a Consultant ENT Surgeon with a
special interest in Head Neck Cancer
Costs identified in January 2004, for a general
ENT surgeon, were 21.6K pay (of which 9.7K
was for Histology) 10.5K (of which 3.9K was
for Histology)
18
Appointment of an Oculoplastic Surgeon

• New post, with 3 theatre sessions identified in
  the job plan
• Initial bid to TMB put in with 10K for 0.1 wte
  consultant histopathologist, plus 15K for
  pathology services
• Discussions resulted in an increase to 0.3 wte
  consultant histopathologist
• We are now awaiting clarification of how the
  15K for pathology services figure was created

19
Transfer of complex gynaecological cancer work
from Tameside and Oldham to St Marys

• Implication for Histology consultant 45K,
  supporting staff 16.5K, nonpay 24.5K
• Implication for other depts, totalling 42.1K

20
News
Pat n Donuts

• Lunch Time talk Sessions
• with Pat
• in the Laboratory Tea Rooms

21
(No Transcript)
22
Fire Lecture
Malcolm Dunlop